208 related articles for article (PubMed ID: 21762804)
1. New approaches for antiviral targeting of HIV assembly.
Prevelige PE
J Mol Biol; 2011 Jul; 410(4):634-40. PubMed ID: 21762804
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Maturation: Lessons Learned from Inhibitors.
Kleinpeter AB; Freed EO
Viruses; 2020 Aug; 12(9):. PubMed ID: 32858867
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
J Virol; 2017 May; 91(9):. PubMed ID: 28202766
[TBL] [Abstract][Full Text] [Related]
4. The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly.
Neira JL
FEBS J; 2009 Nov; 276(21):6110-7. PubMed ID: 19825045
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain.
Zhang H; Curreli F; Zhang X; Bhattacharya S; Waheed AA; Cooper A; Cowburn D; Freed EO; Debnath AK
Retrovirology; 2011 May; 8():28. PubMed ID: 21539734
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors.
Spearman P
Curr Top Med Chem; 2016; 16(10):1154-66. PubMed ID: 26329615
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation.
Novikova M; Adams LJ; Fontana J; Gres AT; Balasubramaniam M; Winkler DC; Kudchodkar SB; Soheilian F; Sarafianos SG; Steven AC; Freed EO
mBio; 2018 Oct; 9(5):. PubMed ID: 30327442
[TBL] [Abstract][Full Text] [Related]
8. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M
Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Capsid Inhibitors as Antiretroviral Agents.
Thenin-Houssier S; Valente ST
Curr HIV Res; 2016; 14(3):270-82. PubMed ID: 26957201
[TBL] [Abstract][Full Text] [Related]
10. [Assembly and maturation of HIV-1--targets for new anti-HIV compounds].
Bukrinskaia AG; Vorkunova GK; Burshteĭn ME
Mol Gen Mikrobiol Virusol; 2005; (1):18-23. PubMed ID: 15790028
[TBL] [Abstract][Full Text] [Related]
11. Targeting the assembly of the human immunodeficiency virus type I.
Muriaux D; Darlix JL; Cimarelli A
Curr Pharm Des; 2004; 10(30):3725-39. PubMed ID: 15579067
[TBL] [Abstract][Full Text] [Related]
12. FAITH - Fast Assembly Inhibitor Test for HIV.
Hadravová R; Rumlová M; Ruml T
Virology; 2015 Dec; 486():78-87. PubMed ID: 26410239
[TBL] [Abstract][Full Text] [Related]
13. Addressing Antiretroviral Drug Resistance with Host-Targeting Drugs-First Steps towards Developing a Host-Targeting HIV-1 Assembly Inhibitor.
Lingappa JR; Lingappa VR; Reed JC
Viruses; 2021 Mar; 13(3):. PubMed ID: 33802145
[TBL] [Abstract][Full Text] [Related]
14. Activity of the small modified amino acid alpha-hydroxy glycineamide on in vitro and in vivo human immunodeficiency virus type 1 capsid assembly and infectivity.
Abdurahman S; Végvári A; Youssefi M; Levi M; Höglund S; Andersson E; Horal P; Svennerholm B; Balzarini J; Vahlne A
Antimicrob Agents Chemother; 2008 Oct; 52(10):3737-44. PubMed ID: 18644965
[TBL] [Abstract][Full Text] [Related]
15. New antiretroviral agents: looking beyond protease and reverse transcriptase.
Miller MD; Hazuda DJ
Curr Opin Microbiol; 2001 Oct; 4(5):535-9. PubMed ID: 11587929
[TBL] [Abstract][Full Text] [Related]
16. Integrative structural biology of HIV-1 capsid protein assemblies: combining experiment and computation.
Perilla JR; Hadden-Perilla JA; Gronenborn AM; Polenova T
Curr Opin Virol; 2021 Jun; 48():57-64. PubMed ID: 33901736
[TBL] [Abstract][Full Text] [Related]
17. Dual-acting stapled peptides target both HIV-1 entry and assembly.
Zhang H; Curreli F; Waheed AA; Mercredi PY; Mehta M; Bhargava P; Scacalossi D; Tong X; Lee S; Cooper A; Summers MF; Freed EO; Debnath AK
Retrovirology; 2013 Nov; 10():136. PubMed ID: 24237936
[TBL] [Abstract][Full Text] [Related]
18. Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes.
Anderson-Daniels J; Singh PK; Sowd GA; Li W; Engelman AN; Aiken C
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413124
[TBL] [Abstract][Full Text] [Related]
19. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG
PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621
[TBL] [Abstract][Full Text] [Related]
20. Identification of an Antiretroviral Small Molecule That Appears To Be a Host-Targeting Inhibitor of HIV-1 Assembly.
Reed JC; Solas D; Kitaygorodskyy A; Freeman B; Ressler DTB; Phuong DJ; Swain JV; Matlack K; Hurt CR; Lingappa VR; Lingappa JR
J Virol; 2021 Jan; 95(3):. PubMed ID: 33148797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
